Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

International Stem Cell (ISCO) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to 0.13%.

  • International Stem Cell's Return on Capital Employed rose 9400.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 9400.0%. This contributed to the annual value of 0.11% for FY2024, which is 14300.0% up from last year.
  • According to the latest figures from Q3 2025, International Stem Cell's Return on Capital Employed is 0.13%, which was up 9400.0% from 0.13% recorded in Q2 2025.
  • International Stem Cell's Return on Capital Employed's 5-year high stood at 0.13% during Q3 2025, with a 5-year trough of 3.22% in Q1 2022.
  • Its 5-year average for Return on Capital Employed is 1.2%, with a median of 0.92% in 2022.
  • As far as peak fluctuations go, International Stem Cell's Return on Capital Employed plummeted by -22300bps in 2021, and later skyrocketed by 27100bps in 2023.
  • Over the past 5 years, International Stem Cell's Return on Capital Employed (Quarter) stood at 2.92% in 2021, then soared by 86bps to 0.4% in 2022, then tumbled by -140bps to 0.97% in 2023, then surged by 86bps to 0.14% in 2024, then skyrocketed by 192bps to 0.13% in 2025.
  • Its last three reported values are 0.13% in Q3 2025, 0.13% for Q2 2025, and 0.36% during Q1 2025.